T2 Biosystems wins Medicare payment approval

By LabPulse.com staff writers

August 7, 2019 -- T2 Biosystems said the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a new technology add-on payment (NTAP) for the firm's T2Bacteria panel sepsis IVD test.

As of October 1, 2019, U.S. hospitals treating Medicare inpatients with sepsis will now be eligible for a maximum NTAP amount of $97.50 -- 65% of the list price for one test -- for the T2Bacteria panel in addition to the appropriate sepsis diagnosis-related group (MS-DRG) reimbursement that hospitals receive under the Medicare hospital inpatient prospective payment system (IPPS), according to T2. The T2Bacteria panel is designed to detect sepsis-causing bacterial pathogens in the bloodstream in three to five hours without a blood culture.

T2 noted that CMS said in its 2020 fiscal year IPPS final rule that the "T2Bacteria test panel represents a substantial clinical improvement over existing technologies because it reduces the proportion of patients on inappropriate therapy, thus reducing the rate of subsequent diagnostic or therapeutic intervention as well as length of stay and mortality rates caused by sepsis-causing bacterial infections."

T2 stretches out globally with sepsis assays
T2 Biosystems is introducing its T2Bacteria and T2Candida whole-blood panel diagnostics in five new countries -- Estonia, Greece, Ireland, Saudi Arabia,...
T2Bacteria panel proves itself, but will hospitals buy in?
The T2Bacteria panel was accurate and fast for detecting five common kinds of bacteria in the blood in a multicenter study published May 13 in the Annals...
Labs gear up to diagnose novel fungal infection
Clinical laboratories are being advised by the U.S. Centers for Disease Control and Prevention on how to handle a relatively new fungal infection, Candida...

Copyright © 2019 LabPulse.com

Last Updated np 8/7/2019 11:24:22 AM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current